G01N 2800/361
Menstrual abnormalities or abnormal uterine bleeding
Official title: Menstrual abnormalities or abnormal uterine bleeding, e.g. dysmenorrhea
G01N2800/361 (Menstrual abnormalities or abnormal uterine bleeding) appears on 6 US grants and 20 published applications in this corpus.
Search patents in G01N- Granted patents
- 6
- Published applications
- 20
- Assignees
- 15
- Inventors
- 52
- Latest grant
- 2 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 2 |
| 2008 | 1 | 2 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 0 | 2 |
| 2024 | 0 | 3 |
| 2025 | 0 | 0 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Treatment of pain and/or pain related symptoms associated with dysmenorrhea2 Aug 2022US 11,400,059 B2Alyra Biotech Pty Ltd
- Diagnostic markers of human female infertility31 Jan 2012US 8,106,001 B2University of South Florida
- MATER-protein specific antibodies and methods of use12 May 2009US 7,531,635 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods of detection of MATER protein autoantibodies7 Oct 2008US 7,432,067 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health
- Human gene critical to fertility15 May 2007US 7,217,811 B2The United States of America as represented by the Department of Health and Human Services
- Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome5 Feb 2026US 2026/0036594 A1Roche Diagnostics Operations, Inc.
- Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome5 Feb 2026US 2026/0036596 A1Roche Diagnostics Operations, Inc.
- Ratio between lta4h and metrnl in the assessment of polycystic ovarian syndrome5 Feb 2026US 2026/0036599 A1Roche Diagnostics Operations, Inc.
- Biomarker for diagnosing central precocious puberty in females and uses thereof29 Jan 2026US 2026/0029418 A1Affiliated Hospital of Nantong University
- Inhibitors of il-11 or il-11ra for use in the treatment of abnormal uterine bleeding26 Sep 2024US 2024/0317847 A1Bayer Aktiengesellschaft
Most cited
By later US patents
- MATER-protein specific antibodies and methods of use6US 7,531,635 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2009
- Methods of detection of MATER protein autoantibodies3US 7,432,067 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health · 2008